Dong-A ST’s partnership with GSK ends on November

Published: 2016-11-28 13:14:05

Updated: 2016-11-28 13:14:05

Dong-A ST made a notice on the 24^th that the strategic partnership, which was made on May 2010 when they were Dong-A Pharm, to jointly sell the products of GlaxoSmithKline(GSK) with GSK will end on November 30, 2016.

Dong-A ST is jointly selling the total 5 products, including Zeffix, Hepsera, Seretide Evohaler, Avamys and Avodart, with GSK in Korea.

Dong-A ST explained it made the KRW 15.8 ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.